Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
9.69
+0.17 (1.79%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Xencor Market Cap
Xencor has a market cap or net worth of $683.48 million as of April 17, 2025. Its market cap has decreased by -48.04% in one year.
Market Cap
683.48M
Enterprise Value
160.83M
1-Year Change
-48.04%
Ranking
Category
Stock Price
$9.69
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $683.48M, an increase of 178.52%. That is a compound annual growth rate of 9.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 683.50M | -57.50% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.65B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.75B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |